Drostanolone, or dromostanolone, sold under various brand names including Drolban, Masteron, and Masteron among many others, is a corticosteroid and anabolic steroid drug that was originally used to treat invasive breast cancer in women but has since been discontinued. It is usually given orally by injection to the muscle. The manufacturer, Novartis, still holds the patent on the product, and it is not subject to resale under any other brand name. There have been multiple studies supporting its use as an aid for pain relief for non-cancerous minor aches and pains. masteron
The generic name for this drug is “dromostandelone methyl group.” Due to a molecular structure that resembles that of estrogen, it is able to mimic estrogen and behave like it. Because of this action, the effects of these medications are similar to that of estrogen and may help prevent uterine cancer. This property allows for the use of both estrogen and masteron. Because of the similarity of its absorption profile with estrogen, studies have shown that there are lower risks of adverse effects than with other prescription and non-prescription treatments.
While there has been minimal evidence suggesting that there are any negative side effects associated with the use of masteron, its use is not recommended for women with estrogenic side effects. For example, it has been shown that women with aromatase hyperplasia should not use this medication, as it has been shown to cause an increase in aromatase levels. This increase may lead to breast tumors and carcinoma. The safety of this medication has not been proven for benign prostatic hyperplasia, but the link with estrogenic side effects needs to be researched more thoroughly.
Like many of the androgenic side effects seen with DHT inhibitors, there is a positive correlation between the use of masteron and semen quality and production. While there has been some research linking the use of masteron and testicular diseases, there is no direct relationship between the two. Also, the potency and absorption rates of masteron are similar to that of DHT inhibitors, meaning that it would be unlikely that a low dose would have any effect on sperm count or quality. There is also some concern that long-term use of the compound could lead to increased levels of dihydrotestosterone (DHT), which have been shown to reduce sperm motility and have a negative effect on male fertility.
There have been a number of theories surrounding the link between masteron and testosterone. Some have suggested that testosterone is converted into masteron via the same chemical process used in bodybuilding. While this may be partially true, the presence of other hormones such as estrogen could negate the effects of the testosterone, as they have been shown to inhibit the conversion process. Another theory surrounding the relationship of masteron and testosterone is that it may act as a type of female hormone, although this is still being researched. More studies need to be conducted in order to determine the effects of this compound and its side effects on fertility.
As with any testosterone-like compound, high doses of masteron could have adverse effects on human health. It should be used under the care of a doctor or medical professional when administered in doses higher than the recommended dosage. If you are taking an aromatase inhibitor and you notice an adverse reaction, discontinue use immediately and contact your doctor. Taking high doses of masteron can lead to a feminizing condition known as steatohepatitis, which is associated with breast cancer, infertility, and heart disease.